Cargando…
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
BACKGROUND AND PURPOSE: Tumor recurrence after liver transplantation (LT) impedes the curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a deep pathomics score (DPS) for predicting tumor recurrence after liver transplantation using deep learning. PATIENTS AND ME...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386986/ https://www.ncbi.nlm.nih.gov/pubmed/37031334 http://dx.doi.org/10.1007/s12072-023-10511-2 |
_version_ | 1785081796883382272 |
---|---|
author | Qu, Wei-Feng Tian, Meng-Xin Lu, Hong-Wei Zhou, Yu-Fu Liu, Wei-Ren Tang, Zheng Yao, Zhao Huang, Run Zhu, Gui-Qi Jiang, Xi-Fei Tao, Chen-Yang Fang, Yuan Gao, Jun Wu, Xiao-Ling Chen, Jia-Feng Zhao, Qian-Fu Yang, Rui Chu, Tian-Hao Zhou, Jian Fan, Jia Yu, Jin-Hua Shi, Ying-Hong |
author_facet | Qu, Wei-Feng Tian, Meng-Xin Lu, Hong-Wei Zhou, Yu-Fu Liu, Wei-Ren Tang, Zheng Yao, Zhao Huang, Run Zhu, Gui-Qi Jiang, Xi-Fei Tao, Chen-Yang Fang, Yuan Gao, Jun Wu, Xiao-Ling Chen, Jia-Feng Zhao, Qian-Fu Yang, Rui Chu, Tian-Hao Zhou, Jian Fan, Jia Yu, Jin-Hua Shi, Ying-Hong |
author_sort | Qu, Wei-Feng |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Tumor recurrence after liver transplantation (LT) impedes the curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a deep pathomics score (DPS) for predicting tumor recurrence after liver transplantation using deep learning. PATIENTS AND METHODS: Two datasets of 380 HCC patients who underwent LT were enrolled. Residual convolutional neural networks were used to identify six histological structures of HCC. The individual risk score of each structure and DPS were derived by a modified DeepSurv network. Cox regression analysis and Concordance index were used to evaluate the prognostic significance. The cellular exploration of prognostic immune biomarkers was performed by quantitative and spatial proximity analysis according to three panels of 7-color immunofluorescence. RESULTS: The overall classification accuracy of HCC tissue was 97%. At the structural level, immune cells were the most significant tissue category for predicting post-LT recurrence (HR 1.907, 95% CI 1.490–2.440). The C-indices of DPS achieved 0.827 and 0.794 in the training and validation cohorts, respectively. Multivariate analysis for recurrence-free survival (RFS) showed that DPS (HR 4.795, 95% CI 3.017–7.619) was an independent risk factor. Patients in the high-risk subgroup had a shorter RFS, larger tumor diameter and a lower proportion of clear tumor borders. At the cellular level, a higher infiltration of intratumoral NK cells was negatively correlated with recurrence risk. CONCLUSIONS: This study established an effective DPS. Immune cells were the most significant histological structure related to HCC recurrence. DPS performed well in post-LT recurrence prediction and the identification of clinicopathological features. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12072-023-10511-2. |
format | Online Article Text |
id | pubmed-10386986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-103869862023-07-31 Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation Qu, Wei-Feng Tian, Meng-Xin Lu, Hong-Wei Zhou, Yu-Fu Liu, Wei-Ren Tang, Zheng Yao, Zhao Huang, Run Zhu, Gui-Qi Jiang, Xi-Fei Tao, Chen-Yang Fang, Yuan Gao, Jun Wu, Xiao-Ling Chen, Jia-Feng Zhao, Qian-Fu Yang, Rui Chu, Tian-Hao Zhou, Jian Fan, Jia Yu, Jin-Hua Shi, Ying-Hong Hepatol Int Original Article BACKGROUND AND PURPOSE: Tumor recurrence after liver transplantation (LT) impedes the curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a deep pathomics score (DPS) for predicting tumor recurrence after liver transplantation using deep learning. PATIENTS AND METHODS: Two datasets of 380 HCC patients who underwent LT were enrolled. Residual convolutional neural networks were used to identify six histological structures of HCC. The individual risk score of each structure and DPS were derived by a modified DeepSurv network. Cox regression analysis and Concordance index were used to evaluate the prognostic significance. The cellular exploration of prognostic immune biomarkers was performed by quantitative and spatial proximity analysis according to three panels of 7-color immunofluorescence. RESULTS: The overall classification accuracy of HCC tissue was 97%. At the structural level, immune cells were the most significant tissue category for predicting post-LT recurrence (HR 1.907, 95% CI 1.490–2.440). The C-indices of DPS achieved 0.827 and 0.794 in the training and validation cohorts, respectively. Multivariate analysis for recurrence-free survival (RFS) showed that DPS (HR 4.795, 95% CI 3.017–7.619) was an independent risk factor. Patients in the high-risk subgroup had a shorter RFS, larger tumor diameter and a lower proportion of clear tumor borders. At the cellular level, a higher infiltration of intratumoral NK cells was negatively correlated with recurrence risk. CONCLUSIONS: This study established an effective DPS. Immune cells were the most significant histological structure related to HCC recurrence. DPS performed well in post-LT recurrence prediction and the identification of clinicopathological features. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12072-023-10511-2. Springer India 2023-04-08 /pmc/articles/PMC10386986/ /pubmed/37031334 http://dx.doi.org/10.1007/s12072-023-10511-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Qu, Wei-Feng Tian, Meng-Xin Lu, Hong-Wei Zhou, Yu-Fu Liu, Wei-Ren Tang, Zheng Yao, Zhao Huang, Run Zhu, Gui-Qi Jiang, Xi-Fei Tao, Chen-Yang Fang, Yuan Gao, Jun Wu, Xiao-Ling Chen, Jia-Feng Zhao, Qian-Fu Yang, Rui Chu, Tian-Hao Zhou, Jian Fan, Jia Yu, Jin-Hua Shi, Ying-Hong Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
title | Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
title_full | Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
title_fullStr | Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
title_full_unstemmed | Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
title_short | Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
title_sort | development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386986/ https://www.ncbi.nlm.nih.gov/pubmed/37031334 http://dx.doi.org/10.1007/s12072-023-10511-2 |
work_keys_str_mv | AT quweifeng developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT tianmengxin developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT luhongwei developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT zhouyufu developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT liuweiren developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT tangzheng developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT yaozhao developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT huangrun developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT zhuguiqi developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT jiangxifei developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT taochenyang developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT fangyuan developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT gaojun developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT wuxiaoling developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT chenjiafeng developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT zhaoqianfu developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT yangrui developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT chutianhao developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT zhoujian developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT fanjia developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT yujinhua developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation AT shiyinghong developmentofadeeppathomicsscoreforpredictinghepatocellularcarcinomarecurrenceafterlivertransplantation |